Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z5EJ
|
|||
| Drug Name |
PSMA-617
|
|||
| Synonyms |
JBHPLHATEXGMQR-VLOIPPKDSA-N; UNII-4YM1W0EGQ5; 4YM1W0EGQ5; SCHEMBL20180896; HY-117410; CS-0065894
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0] | Phase 2 | [1] | |
| Company |
EndocyteWest Lafayette, INRadio MedixHouston, TX
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C49H71N9O16
|
|||
| Canonical SMILES |
C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O
|
|||
| InChI |
1S/C49H71N9O16/c59-40(28-55-17-19-56(29-42(62)63)21-23-58(31-44(66)67)24-22-57(20-18-55)30-43(64)65)51-27-32-8-12-35(13-9-32)45(68)52-39(26-33-10-11-34-5-1-2-6-36(34)25-33)46(69)50-16-4-3-7-37(47(70)71)53-49(74)54-38(48(72)73)14-15-41(60)61/h1-2,5-6,10-11,25,32,35,37-39H,3-4,7-9,12-24,26-31H2,(H,50,69)(H,51,59)(H,52,68)(H,60,61)(H,62,63)(H,64,65)(H,66,67)(H,70,71)(H,72,73)(H2,53,54,74)/t32?,35?,37-,38-,39-/m0/s1
|
|||
| InChIKey |
JBHPLHATEXGMQR-VLOIPPKDSA-N
|
|||
| CAS Number |
CAS 1702967-37-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.